Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1136584615 | 11365846 | 15 | F | 20150727 | 20160708 | 20150811 | 20160721 | EXP | DE-TEVA-584625ISR | TEVA | 89.57 | YR | M | Y | 68.00000 | KG | 20160721 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1136584615 | 11365846 | 1 | PS | WARFARIN | WARFARIN | 1 | Oral | 3 MILLIGRAM DAILY; | Y | N | 40145 | 3 | MG | TABLET | QD | ||||
1136584615 | 11365846 | 2 | SS | WARFARIN | WARFARIN | 1 | Oral | 10 MILLIGRAM DAILY; | Y | N | 40145 | 10 | MG | TABLET | QD | ||||
1136584615 | 11365846 | 3 | SS | WARFARIN | WARFARIN | 1 | Oral | 5 MILLIGRAM DAILY; | Y | N | 40145 | 5 | MG | TABLET | QD | ||||
1136584615 | 11365846 | 4 | SS | WARFARIN | WARFARIN | 1 | Oral | 5 MILLIGRAM DAILY; | Y | N | 40145 | 5 | MG | TABLET | QD | ||||
1136584615 | 11365846 | 5 | SS | WARFARIN | WARFARIN | 1 | Oral | 1 MILLIGRAM DAILY; | Y | N | 40145 | 1 | MG | TABLET | QD | ||||
1136584615 | 11365846 | 6 | SS | WARFARIN | WARFARIN | 1 | Oral | 1 MILLIGRAM DAILY; | Y | N | 40145 | 1 | MG | TABLET | QD | ||||
1136584615 | 11365846 | 7 | SS | WARFARIN | WARFARIN | 1 | Oral | 3 MILLIGRAM DAILY; TUE, THU, SAT | Y | N | 40145 | 3 | MG | TABLET | QD | ||||
1136584615 | 11365846 | 8 | SS | WARFARIN | WARFARIN | 1 | Oral | 1 MILLIGRAM DAILY; MO, WE, FR, SUN | Y | N | 40145 | 1 | MG | TABLET | QD | ||||
1136584615 | 11365846 | 9 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | 100 MILLIGRAM DAILY; | Y | U | 0 | 100 | MG | QD | |||||
1136584615 | 11365846 | 10 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | 100 MILLIGRAM DAILY; | Y | U | 0 | 100 | MG | QD | |||||
1136584615 | 11365846 | 11 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MILLIGRAM DAILY; ONGOING | 76999 | 75 | MG | QD | |||||||
1136584615 | 11365846 | 12 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MILLIGRAM DAILY; | 76999 | 75 | MG | QD | |||||||
1136584615 | 11365846 | 13 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 1000 MILLIGRAM DAILY; | U | 74124 | 500 | MG | BID | ||||||
1136584615 | 11365846 | 14 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MILLIGRAM DAILY; | U | 0 | 40 | MG | QD | ||||||
1136584615 | 11365846 | 15 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | U | 0 | |||||||||||
1136584615 | 11365846 | 16 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MILLIGRAM DAILY; | 0 | 40 | MG | QD | |||||||
1136584615 | 11365846 | 17 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 23.5 MILLIGRAM DAILY; | 0 | 23.5 | MG | QD | |||||||
1136584615 | 11365846 | 18 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | 2.5 MILLIGRAM DAILY; | 0 | 2.5 | MG | QD | |||||||
1136584615 | 11365846 | 19 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MILLIGRAM DAILY; | 0 | 40 | MG | QD | |||||||
1136584615 | 11365846 | 20 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 120 MILLIGRAM DAILY; | 0 | 40 | MG | TID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
1136584615 | 11365846 | 1 | Atrial fibrillation |
1136584615 | 11365846 | 2 | Coronary artery disease |
1136584615 | 11365846 | 9 | Coronary artery disease |
1136584615 | 11365846 | 11 | Coronary artery disease |
1136584615 | 11365846 | 13 | Pseudomonas infection |
1136584615 | 11365846 | 14 | Gastritis |
1136584615 | 11365846 | 15 | Prophylaxis |
1136584615 | 11365846 | 16 | Hypertension |
1136584615 | 11365846 | 17 | Hypertension |
1136584615 | 11365846 | 18 | Hypertension |
1136584615 | 11365846 | 19 | Cardiac failure |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
1136584615 | 11365846 | HO |
1136584615 | 11365846 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
1136584615 | 11365846 | Abdominal pain | |
1136584615 | 11365846 | Angina unstable | |
1136584615 | 11365846 | Bursitis | |
1136584615 | 11365846 | Cardiac failure | |
1136584615 | 11365846 | Chronic gastritis | |
1136584615 | 11365846 | Dyspnoea | |
1136584615 | 11365846 | Epistaxis | |
1136584615 | 11365846 | Haematemesis | |
1136584615 | 11365846 | Haematocrit decreased | |
1136584615 | 11365846 | Haemoglobin decreased | |
1136584615 | 11365846 | International normalised ratio increased | |
1136584615 | 11365846 | Mucosal haemorrhage | |
1136584615 | 11365846 | Pseudomonas infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
1136584615 | 11365846 | 1 | 20150717 | 20150719 | 0 | |
1136584615 | 11365846 | 2 | 20150720 | 20150727 | 0 | |
1136584615 | 11365846 | 3 | 20150728 | 20150730 | 0 | |
1136584615 | 11365846 | 4 | 20150804 | 0 | ||
1136584615 | 11365846 | 5 | 20150807 | 20150811 | 0 | |
1136584615 | 11365846 | 6 | 20150814 | 0 | ||
1136584615 | 11365846 | 7 | 20150910 | 0 | ||
1136584615 | 11365846 | 8 | 20150910 | 0 | ||
1136584615 | 11365846 | 9 | 1999 | 20150804 | 0 | |
1136584615 | 11365846 | 10 | 20150812 | 20150813 | 0 | |
1136584615 | 11365846 | 11 | 20150717 | 0 | ||
1136584615 | 11365846 | 12 | 201506 | 0 | ||
1136584615 | 11365846 | 13 | 20151019 | 0 | ||
1136584615 | 11365846 | 14 | 20150804 | 0 | ||
1136584615 | 11365846 | 16 | 20150714 | 0 | ||
1136584615 | 11365846 | 17 | 20150713 | 0 | ||
1136584615 | 11365846 | 18 | 2010 | 0 | ||
1136584615 | 11365846 | 19 | 20150713 | 0 | ||
1136584615 | 11365846 | 20 | 20150915 | 20151026 | 0 |